Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.

Schwid, Steven R; Bausch, Janice; Oakes, David; Schuchter, Lynn; Tanner, Caroline; Forrest, Misser; Lang, Anthony E; Shoulson, Ira; Shoulson, Ira; Hyson, Christopher; Oakes, David; Flagg, Emily; Rudolph, Alice; Kieburtz, Karl; Lang, Anthony; Fahn, Stanley; Gauger, Lisa; Goetz, Christopher

Schwid, Steven R; Bausch, Janice; Oakes, David; Schuchter, Lynn; Tanner, Caroline; Forrest, Misser; Lang, Anthony E; Shoulson, Ira; Shoulson, Ira; Hyson, Christopher; Oakes, David; Flagg, Emily; Rudolph, Alice; Kieburtz, Karl; Lang, Anthony; Fahn, Stanley; Gauger, Lisa; Goetz, Christopher.

Affiliation

Schwid SR; Department of Neurology, University of Rochester, Rochester, New York, USA.

Mov Disord ; 25(12): 1801-8, 2010 Sep 15.

Article in En | MEDLINE | ID: mdl-20669311

Subject(s)

Carbazoles/adverse effects; Neoplasms/epidemiology; Neoplasms/etiology; Parkinson Disease/drug therapy; Parkinson Disease/epidemiology; Aged; Carbazoles/therapeutic use; Chi-Square Distribution; Comorbidity; Disease Progression; Double-Blind Method; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Middle Aged

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Carbazoles / Neoplasms Type of study: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Middle aged Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2010 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google